ICCR肝内胆管癌、肝门部胆管癌及肝细胞癌病理报告数据集推荐
国际癌症报告协作组织(ICCR)专家小组制定了针对肝内胆管癌、肝门部胆管癌和肝细胞癌的循证病理报告数据集,列出报告中应包含的「必需」和「推荐」要素并附解释性评论。该数据集采纳了WHO肝脏恶性肿瘤第4版的定义与分类以及TNM第8版分期系统,旨在统一癌症报告、便于不同人群间流行病学与病理参数比较并促进研究。
要点
- 报告应包含数据集规定的「必需」和「推荐」要素,并以解释性评论辅助填写。
- 数据集采用WHO第4版肝脏恶性肿瘤分类和TNM第8版分期系统。
- 推广实施该数据集有助于数据采集一致、人群间比较和改善患者结局。
核心结论
- ICCR专家小组制定了肝内胆管癌、肝门部胆管癌和肝细胞癌的病理报告数据集,包含「必需」和「推荐」要素及解释性评论。
- 该数据集的广泛采用与实施将有助于一致、准确的数据采集,促进不同人群间流行病学和病理参数的比较,并最终改善患者结局。
研究设计与样本
- ICCR由澳大利亚皇家病理学家学院、英国皇家病理学家学院、美国病理学家学会、加拿大抗癌伙伴关系、欧洲病理学会和美国临床病理学会组成联盟,旨在为每个癌症部位制定循证报告数据集。
- 本文描述ICCR专家小组针对主要肝脏恶性肿瘤(肝内胆管癌、肝门部胆管癌和肝细胞癌)报告数据集的制定,并呈现报告中的「必需」和「推荐」要素及解释性评论。
主要发现
- 数据集采纳了最新WHO肝脏恶性肿瘤出版物(第4版)中的定义与分类,以及近期发布的TNM第8版分期系统。
- 作者认为,由ICCR统一制定数据集可减少全球癌症数据集开发负担,并减少不同国际机构重复投入。
关键数值与推荐
- 报告要素分为「必需」和「推荐」两类,具体条目未在原文中列出。
- 数据集整合WHO第4版肝脏恶性肿瘤分类和TNM第8版分期系统。
临床怎么用
- 病理科医生可按该数据集结构化报告肝内胆管癌、肝门部胆管癌和肝细胞癌,以支持分期与预后判断。
- 推广采用该数据集可促进跨国家、跨人群的病理与流行病学数据比较及研究。
局限性
- 原文未报告数据集的验证结果、实施效果或具体要素清单。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Optimal patient management benefits from comprehensive and accurate pathology reports that contribute to cancer staging and prognostication. Proforma reports are used in many countries, but these vary in their structure and implementation. The International Collaboration on Cancer Reporting (ICCR) is an alliance formed by the Royal College of Pathologists of Australasia, the Royal College of Pathologists of the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer the European Society of Pathology and the American Society of Clinical Pathology (ASCP), with the aim of developing an evidence-based reporting data set for each cancer site. It is argued that this should reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardised cancer reporting data sets. The resultant standardisation of cancer reporting will benefit not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of a cancer data set by the ICCR expert panel for the reporting of the main malignant liver tumours: intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma and present the 'required' and 'recommended' elements to be included in the report with an explanatory commentary. This data set incorporates definitions and classifications in the most recent World Health Organisation (WHO) publication on hepatic malignancies (4th edition) and the recently published tumour-node-metastasis (TNM)8 staging system. Widespread adoption and implementation of this data set will enable consistent and accurate data collection, comparison of epidemiological and pathological parameters between different populations, facilitate research and ultimately result in better patient outcomes.
引用
- Burt AD, Alves V, Bedossa P, et al. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology. 2018. PMID: 29573451. doi:10.1111/his.13520
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。